Representative before the EPO

Employment test 51 - 200 employees
Company dna maiwald patentanwalts gmbh
operating since 1995
Headquarter in Munich and 4 offices
active in Legal Services and IP Consulting

Martin Huenges has worked on the following 85 EPO patent applications which have been published in the last five years:

EP11708856

POSITIONING UNIT FOR A FUNCTIONAL UNIT

IPC classification:
B01F 11/00, B01L 9/00, B06B 1/12
Applicant:
Quantifoil Instruments Gmbh
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
EXAMINATION IN PROGRESS
EP12169728

Assays

IPC classification:
B01L 3/00
Applicant:
Alere Technologies GmbH
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
EXAMINATION IN PROGRESS
EP12179550

Assay devices and methods for the detection of analytes

IPC classification:
B01L 3/00, C12Q 1/68
Applicant:
Alere Technologies GmbH
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
GRANT OF PATENT INTENDED
EP12169746

Assays in closed fluid circuit

IPC classification:
B01L 3/00
Applicant:
Alere Technologies GmbH
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
GRANT OF PATENT INTENDED
EP12701298

COMPOSITIONS COMPRISING CROSSLINKED CATION- BINDING POLYMERS AND A BASE, USES THEREOF

IPC classification:
A23L 1/00, A61K 9/16
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12701299

COMPOSITIONS COMPRISING CROSSLINKED CATION- BINDING POLYMERS AND CALCIUM AND/OR MAGNESIUM CATIONS, AND USES THEREOF

IPC classification:
A61K 9/16
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12192879

Assays

IPC classification:
B01L 3/00
Applicant:
Alere Technologies GmbH
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
EXAMINATION IN PROGRESS
EP12192881

Assays

IPC classification:
B01L 3/00, C12Q 1/68, C12Q 1/70
Applicant:
Alere Technologies GmbH
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
EXAMINATION IN PROGRESS
EP13152271

assays in microfluidic devices with flexible substrates

IPC classification:
B01L 3/00
Applicant:
Alere Technologies GmbH
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
GRANT OF PATENT INTENDED
EP12192872

Assays

IPC classification:
B01L 3/00, C12Q 1/68, C12Q 1/70
Applicant:
Alere Technologies GmbH
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
GRANT OF PATENT INTENDED
EP12789707

HIGH THROUGHPUT METHYLATION DETECTION METHOD

IPC classification:
C12N 15/11, C12Q 1/68, C40B 20/04, C40B 40/08, C40B 50/06
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
EXAMINATION IN PROGRESS
EP12192877

Assays

IPC classification:
B01L 3/00, C12Q 1/00
Applicant:
Alere Technologies GmbH
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
EXAMINATION IN PROGRESS
EP11734954

DEVICE FOR COLLECTING AND ANALYZING MIGRATORY TUMOR CELLS

IPC classification:
G01N 33/50, A61B 10/00, A61B 10/02
Applicant:
The State University of New York
Applicant:
Albert Einstein College of Medicine Inc.
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12833860

THERAPEUTICS USING ADIPOSE CELLS AND CELL SECRETIONS

IPC classification:
A61P 17/00, A61P 19/02, A61P 25/02, A61P 29/00, A61P 37/00, C12N 1/04, C12N 5/077, C12N 5/0775, A61K 35/12
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
EXAMINATION IN PROGRESS
EP11875013

APPLICATION OF ROSEBURIA IN TREATING AND PREVENTING OBESITY RELATED DISEASES

IPC classification:
A61P 3/04, A61P 3/10, C12R 1/01, A61K 35/74
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
EXAMINATION IN PROGRESS
EP12791213

ISOTOPIC LABELING OF HIGHER ORGANISMS

IPC classification:
C12N 5/00, G01N 33/68
Applicant:
Silantes GmbH
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
EXAMINATION IN PROGRESS
EP12757105

PHARMACEUTICAL COMPOSITIONS AND TOPICAL USE THEREOF

IPC classification:
A61P 17/00, A61P 17/02, A61P 17/10, A61P 17/12, A61P 17/14, A61Q 7/00, A61K 35/12, A61K 35/28
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
PATENT GRANTED
EP13702627

COG-BASED MECHANISM FOR GENERATING AN ORBITAL SHAKING MOTION

IPC classification:
B01F 11/00, B04B 1/02, B06B 1/16
Applicant:
Quantifoil Instruments Gmbh
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13701672

MECHANISM FOR GENERATING AN ORBITAL MOTION OR A ROTATION MOTION BY INVERSING A DRIVE DIRECTION OF A DRIVE UNIT

IPC classification:
B01F 11/00, B04B 1/02, B06B 1/16
Applicant:
Quantifoil Instruments Gmbh
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11848024

STEROID TETROL SOLID STATE FORMS-2

IPC classification:
C07J 1/00, A61K 31/568
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12865785

METHOD AND SYSTEM FOR DETERMINING WHETHER COPY NUMBER VARIATION EXISTS IN SAMPLE GENOME, AND COMPUTER READABLE MEDIUM

IPC classification:
C12N 15/10, C12Q 1/68, G06F 19/00
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
EXAMINATION IN PROGRESS
EP11737389

METHODS FOR DETERMINING AGENTS TARGETING MENA ISOFORMS AND USES THEREOF FOR DIAGNOSIS AND TREATMENT OF METASTATIC TUMORS

IPC classification:
G01N 33/53
Applicant:
Massachusetts Institute of Technology (MIT) Inc.
Applicant:
Albert Einstein College of Medicine Inc.
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13725328

TRI-SUBSTITUTED GLYCEROL COMPOUNDS FOR USE IN THE TREATMENT OF CLINICALLY ISOLATED SYNDROME AND/OR MULTIPLE SCLEROSIS

IPC classification:
A61P 25/00, A61K 31/047, A61K 31/10, A61K 31/685
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
EXAMINATION IN PROGRESS
EP13729363

V1B RECEPTOR ANTAGONIST FOR USE IN THE TREATMENT OF PATIENTS HAVING AN ELEVATED AVP LEVEL AND/OR AN ELEVATED COPEPTIN LEVEL

IPC classification:
C07K 14/575, G01N 33/68, A61K 31/404, A61K 45/00
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
GRANT OF PATENT INTENDED
EP13817599

RISK STRATIFICATION IN INFLUENZA

IPC classification:
C12Q 1/68, C12Q 1/70, G01N 33/53
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
GRANT OF PATENT INTENDED
EP12194076

Absorbent polymeric compositions with varying counterion content and their methods of preparation and use

IPC classification:
C08F 8/00, C08F 20/00, C08F 220/06, C08F 222/10, C08J 3/12, A61K 9/16, A61K 9/48, A61K 31/78, A61L 15/60
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13748253

METHODS OF PRODUCING SWEET JUICE COMPOSITIONS

IPC classification:
A23L 1/015, A23L 1/236
Applicant:
Guilin GFS Monk Fruit Corporation
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
PATENT GRANTED
EP13831228

POLYMERIC AND SOLID-SUPPORTED CATALYSTS, AND METHODS OF DIGESTING CELLULOSIC MATERIALS USING SUCH CATALYSTS

IPC classification:
B01J 21/08, B01J 21/10, B01J 31/08
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
GRANT OF PATENT INTENDED
EP13830609

POLYMERIC AND SOLID-SUPPORTED CATALYSTS, AND METHODS OF DIGESTING LIGNIN-CONTAINING MATERIALS USING SUCH CATALYSTS

IPC classification:
B01J 31/06, B01J 37/04
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13836701

COMPOSITIONS TARGETING BRADYKININ RECEPTOR B1 FOR MEDICAL IMAGING OF CANCER AND OTHER DISORDERS

IPC classification:
A61P 35/00, A61K 51/04
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
GRANT OF PATENT INTENDED
EP14199188

Fused heteroaromatic pyrrolidinones as syk inhibitors

IPC classification:
A61P 7/00, A61P 11/00, A61P 17/00, A61P 19/00, A61P 29/00, A61P 35/00, A61P 37/00, C07D 471/04, C07D 487/04, A61K 31/437, A61K 31/519
Applicant:
Takeda Pharmaceutical Company Limited
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Agent:
D Young & Co LLP
Status:
EXAMINATION IN PROGRESS
EP13840667

THERAPEUTICS USING MULTIPLE INJECTIONS OF CELLS

IPC classification:
A61P 19/02, C12N 5/07
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
GRANT OF PATENT INTENDED
EP12194070

Absorbent polymeric compositions with varying counterion content and their methods of preparation and use

IPC classification:
C08F 2/32, C08F 8/00, C08F 220/06, C08J 3/12, A61K 9/16, A61K 9/48, A61K 31/78, A61L 15/60
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11805884

PROTECTION FROM LETHAL IRRADIATION WITH MESENCHYMAL STROMAL CELLS

IPC classification:
C12N 5/077
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13795450

NUCLEIC ACID ASSAY FOR DIAGNOSING OR MONITORING A PATHOGEN INFECTION IN A BODILY FLUID FROM A SUBJECT TREATED WITH AN ANTI-PATHOGENIC AGENT

IPC classification:
C12Q 1/68
Applicant:
Alere Technologies GmbH
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
EXAMINATION IN PROGRESS
EP13862640

METHODS FOR DIAGNOSING AND TREATING PROSTATE CANCER

IPC classification:
G01N 33/574
Applicant:
Cornell University
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
GRANT OF PATENT INTENDED
EP13867300

VACCINES FOR THE TREATMENT OF CANCER AND COMPOSITIONS FOR ENHANCING VACCINE EFFICACY

IPC classification:
A61P 35/00, C12N 5/077, C12N 5/0775, A61K 38/00, A61K 39/00
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
GRANT OF PATENT INTENDED
EP13874559

PREPARING TOOTH-LIKE STRUCTURE USING STEM CELL

IPC classification:
A61P 1/02, C07K 14/51, C12N 5/0735, C12N 5/074, C12N 5/0775, C12N 5/0789, C12N 5/0797, A61K 6/00
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
EXAMINATION REQUESTED
EP14757595

METHOD FOR PRODUCING SULFONYL CHLORIDE COMPOUND

IPC classification:
C07D 213/71, C07D 401/12
Applicant:
Takeda Pharmaceutical Company Limited
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
EXAMINATION REQUESTED
EP13722922

METHODS OF PRODUCING ENRICHED POPULATIONS OF TUMOR-REACTIVE T CELLS FROM TUMOR

IPC classification:
C12N 5/0783, A61K 35/14
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
EXAMINATION IN PROGRESS
EP13725231

METHODS OF PRODUCING ENRICHED POPULATIONS OF TUMOR REACTIVE T CELLS FROM PERIPHERAL BLOOD

IPC classification:
C12N 5/0783, G01N 33/50, G01N 33/569, A61K 35/14
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
EXAMINATION IN PROGRESS
EP15166799

METHODS AND MATERIALS FOR TARGETED MUTAGENESIS

IPC classification:
C12N 15/10
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14716610

PLASMID FOR MINICIRCLE PRODUCTION

IPC classification:
C12N 15/00, C12N 15/64, C12N 15/79
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
EXAMINATION IN PROGRESS
EP13170036

DEVICE AND PROCESS FOR ASSAYS USING BINDING MEMBERS

IPC classification:
B01J 19/00, B01L 3/00, B01L 7/00, B01L 9/00, C12Q 1/68, C12Q 1/70
Applicant:
Alere Technologies GmbH
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14734461

APPLICATION-SPECIFIC SAMPLE PROCESSING BY MODULES SURROUNDING A ROTOR MECHANISM FOR SAMPLE MIXING AND SAMPLE SEPARATION

IPC classification:
B04B 5/10, G01N 35/00
Applicant:
Quantifoil Instruments Gmbh
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
EXAMINATION IN PROGRESS
EP14818491

PRODUCTION METHOD FOR POLYAMINO ACID

IPC classification:
C08G 69/10, C08G 69/48, A61K 39/39
Applicant:
Takeda Pharmaceutical Company Limited
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
GRANT OF PATENT INTENDED
EP14745056

METHODS OF PREPARING ANTI-HUMAN PAPILLOMAVIRUS ANTIGEN T CELLS

IPC classification:
C12N 5/0783, A61K 35/14
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
EXAMINATION IN PROGRESS
EP14748353

ANTI-HUMAN PAPILLOMAVIRUS 16 E6 T CELL RECEPTORS

IPC classification:
C07K 14/725
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
EXAMINATION IN PROGRESS
EP14834874

METHOD FOR PRODUCING DOPAMINERGIC NEURONS

IPC classification:
A61P 25/16, C12N 5/0793, A61K 35/12, A61L 27/00
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
GRANT OF PATENT INTENDED
EP14834225

AROMATIC COMPOUND

IPC classification:
A61P 3/10, A61P 43/00, C07D 211/22, C07D 401/10, C07D 401/12, C07D 401/14, C07D 405/12, C07D 405/14, C07D 409/12, C07D 413/10, C07D 413/14, C12N 15/09, A61K 31/451, A61K 31/453, A61K 31/4535, A61K 31/454, A61K 31/4545, A61K 31/497, A61K 31/506, A61K 31/5377
Applicant:
Takeda Pharmaceutical Company Limited
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
GRANT OF PATENT INTENDED
EP14851360

BIOMARKERS FOR CELL THERAPY

IPC classification:
A61P 1/00, A61P 19/02, A61P 37/00, G01N 33/68, A61K 35/12
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
GRANT OF PATENT INTENDED
EP14856224

HETEROCYCLIC COMPOUND

IPC classification:
A61P 25/18, A61P 25/28, A61P 43/00, C07D 239/28, C07D 239/36, C07D 239/42, C07D 239/47, C07D 239/48, C07D 239/54, C07D 239/56, C07D 241/24, C07D 241/26, C07D 277/20, A61K 31/426, A61K 31/4965, A61K 31/497, A61K 31/505, A61K 31/506, A61K 31/5377, A61K 31/5386, A61K 31/55
Applicant:
Takeda Pharmaceutical Company Limited
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
EXAMINATION REQUESTED
EP14803288

METHOD FOR SUBTYPING LYMPHOMA TYPES BY MEANS OF EXPRESSION PROFILING

IPC classification:
C12Q 1/68
Applicant:
Julius-Maximilians-University of Wuerzburg (Universität Würzburg)
Applicant:
University of Nebraska
Applicant:
University of Arizona
Applicant:
Universitat de Barcelona - Centre de Patentes
Applicant:
Oregon Health & Science University
Applicant:
Hospital Clínic de Barcelona
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
EXAMINATION REQUESTED
EP14802259

THYMIC STROMAL LYMPHOPOIETIN RECEPTOR-SPECIFIC CHIMERIC ANTIGEN RECEPTORS AND METHODS USING SAME

IPC classification:
C07K 14/725, C07K 16/30, C07K 16/46
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
EXAMINATION REQUESTED
EP14870738

MICRONEEDLE

IPC classification:
A61K 9/00, A61K 39/00, A61K 39/12, A61K 39/145, A61K 47/10, A61K 47/24, A61K 47/26, A61K 47/36
Applicant:
Takeda Pharmaceutical Company Limited
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
EXAMINATION REQUESTED
EP14870867

WNT PATHWAY MODULATORS

IPC classification:
A61P 17/06, A61P 19/02, A61P 35/00, C07D 487/04, A61K 31/4162
Applicant:
Agency for Science, Technology and Research
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
EXAMINATION REQUESTED
EP14871224

MALEIMIDE DERIVATIVES AS MODULATORS OF WNT PATHWAY

IPC classification:
C07D 471/04, A61K 31/437
Applicant:
Agency for Science, Technology and Research
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
EXAMINATION REQUESTED
EP14833295

4-(PIPERRAZIN-1-YL)-PYRROLIDIN-2-ONE COMPOUNDS AS MONOACYLGLYCEROL LIPASE (MAGL) INHIBITORS

IPC classification:
A61P 25/00, C07D 403/04, C07D 405/12, C07D 413/12, C07D 417/12, C07D 417/14, A61K 31/496
Applicant:
Takeda Pharmaceutical Company Limited
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
EXAMINATION REQUESTED
EP15701450

ANTI-VIRAL CNIDARINS

IPC classification:
C07K 14/435, A61K 38/00
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
EXAMINATION REQUESTED
EP15701442

ANTIBODY TARGETING CELL SURFACE DEPOSITED COMPLEMENT PROTEIN C3d AND USE THEREOF

IPC classification:
A61P 35/02, C07K 16/18, C07K 16/30
Applicant:
University of Virginia Patent Foundation
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
EXAMINATION IN PROGRESS
EP15704963

NUCLEOSOME SUBSTRATE ASSAYS

IPC classification:
C12N 15/10, G01N 33/542, G01N 33/573, G01N 33/58, G01N 33/68
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
EXAMINATION REQUESTED
EP15706080

ANTI-NY-BR-1 POLYPEPTIDES, PROTEINS, AND CHIMERIC ANTIGEN RECEPTORS

IPC classification:
C07K 16/30
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
EXAMINATION REQUESTED
EP15707584

METHODS FOR DETECTING MULTIPLE NUCLEIC ACIDS IN A SAMPLE

IPC classification:
C12Q 1/68
Applicant:
Alere Technologies GmbH
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
EXAMINATION REQUESTED
EP15761818

PYRIDAZINE COMPOUND

IPC classification:
A61P 35/00, A61P 43/00, C07D 401/14, C07D 413/14, C07D 417/14, A61K 31/501
Applicant:
Takeda Pharmaceutical Company Limited
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
APPLICATION WITHDRAWN
EP15722809

HIGH ACTIVITY HYDROTREATING CATALYSTS

IPC classification:
B01J 31/04, C10G 45/08
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
EXAMINATION REQUESTED
EP16189800

METHODS OF PRODUCING SWEET JUICE COMPOSITIONS

IPC classification:
A23L 27/30, A23L 2/04, A23L 2/78
Applicant:
Guilin GFS Monk Fruit Corporation
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP15729304

CHIMERIC ANTIGEN RECEPTORS TARGETING CD-19

IPC classification:
C07K 16/28
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
EXAMINATION REQUESTED
EP15729004

ANTI-HUMAN PAPILLOMAVIRUS 16 E7 T CELL RECEPTORS

IPC classification:
C07K 14/725, A61K 38/17
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
EXAMINATION REQUESTED
EP16198796

SMALL MOLECULE INHIBITORS OF TRPA1

IPC classification:
A61P 17/00, A61Q 19/00, A61K 8/36, A61K 31/192
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP16184030

PHARMACEUTICAL COMPOSITIONS AND TOPICAL USE THEREOF

IPC classification:
A61P 17/00, A61P 17/02, A61P 17/10, A61P 17/12, A61P 17/14, A61Q 7/00, A61K 35/12, A61K 35/28
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
APPLICATION PUBLISHED
EP16204878

DEVICE AND METHOD FOR DETECTING MOLECULAR INTERACTIONS

IPC classification:
B01L 3/00, B01L 7/00, C12Q 1/68, G01N 21/03, G01N 21/64
Applicant:
Alere Technologies GmbH
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
APPLICATION PUBLISHED
EP15824842

USE OF MULTIPLE TARGET NUCLEIC ACID DETECTION METHOD USING CLAMPING PROBE AND DETECTION PROBE

IPC classification:
C12Q 1/68
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
EXAMINATION REQUESTED
EP15838199

METHODS FOR TREATMENT AND PREVENTION OF VASCULAR DISEASE

IPC classification:
A61P 9/00, A61P 9/14, A61F 2/82, A61K 38/16, A61L 27/22, A61L 27/54
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP15840620

HETEROCYCLIC COMPOUND

IPC classification:
A61P 1/00, A61P 11/00, C07D 239/96, A61K 31/517, A61K 31/5377, A61K 31/541, A61K 31/55, A61K 31/551
Applicant:
Takeda Pharmaceutical Company Limited
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP15757074

LENTIVIRAL VECTOR FOR TREATING HEMOGLOBIN DISORDERS

IPC classification:
C12N 5/10, C12N 15/86, A61K 48/00
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP15788249

ADENOVIRAL VECTOR ENCODING HUMAN ATONAL HOMOLOG-1 (HATH1)

IPC classification:
C07K 14/47, C12N 15/861, A61K 48/00
Applicant:
GenVec Inc
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP14790878

METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A CANCER-SPECIFIC MUTATION

IPC classification:
A61P 35/00, C12N 5/0783
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP14796317

METHODS OF ISOLATING T CELL RECEPTORS HAVING ANTIGENIC SPECIFICITY FOR A CANCER-SPECIFIC MUTATION

IPC classification:
C07K 14/47, C07K 14/725, C12N 5/0783, A61K 39/00
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP15802225

METHODS FOR PRODUCING FUELS, GASOLINE ADDITIVES, AND LUBRICANTS USING AMINE CATALYSTS

IPC classification:
B01J 31/02, C07C 45/74, C10L 1/02
Applicant:
BP Corporation North America Inc.
Applicant:
University of California
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP15802226

METHODS FOR PRODUCING FUELS, GASOLINE ADDITIVES, AND LUBRICANTS USING AMINE CATALYSTS

IPC classification:
B01J 31/02, C07C 45/71, C10L 1/02
Applicant:
BP Corporation North America Inc.
Applicant:
University of California
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP15807756

ANTI-MUTATED KRAS T CELL RECEPTORS

IPC classification:
C07K 14/82, A61K 39/00, A61K 45/06
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP15808247

ANTI-CARBAPENEMASE ANTIBODIES AND USES THEREOF

IPC classification:
C07K 16/12, G01N 33/573
Applicant:
Alere Technologies GmbH
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP15868687

IMPROVED CELL THERAPIES

IPC classification:
A61P 29/00, C12N 5/071, C12N 5/077, A61K 35/545
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP15718065

ANTI-CD70 CHIMERIC ANTIGEN RECEPTORS

IPC classification:
C07K 14/705, C07K 14/715, C07K 14/725, C07K 16/30
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP16702008

DETOXIFICATION AND STABILIZATION OF IMPLANTABLE OR TRANSPLANTABLE BIOLOGICAL MATERIAL

IPC classification:
A61L 27/36
Applicant:
University of the Free State
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
Request for examination was made

Please Sign in to use this feature